{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:40:38Z","timestamp":1792716038880,"version":"4.5.0"},"reference-count":207,"publisher":"MDPI AG","issue":"2","license":[{"start":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T00:00:00Z","timestamp":1464220800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Targeted delivery of chemotherapeutics and diagnostic agents conjugated to carrier ligands has made significant progress in recent years, both in regards to the structural design of the conjugates and their biological effectiveness. The goal of targeting specific cell surface receptors through structural compatibility has encouraged the use of peptides as highly specific carriers as short peptides are usually non-antigenic, are structurally simple and synthetically diverse. Recent years have seen many developments in the field of peptide based drug conjugates (PDCs), particularly for cancer therapy, as their use aims to bypass off-target side-effects, reducing the morbidity common to conventional chemotherapy. However, no PDCs have as yet obtained regulatory approval. In this review, we describe the evolution of the peptide-based strategy for targeted delivery of chemotherapeutics and discuss recent innovations in the arena that should lead in the near future to their clinical application.<\/jats:p>","DOI":"10.3390\/biomedicines4020011","type":"journal-article","created":{"date-parts":[[2016,5,26]],"date-time":"2016-05-26T12:13:20Z","timestamp":1464264800000},"page":"11","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":76,"title":["Recent Innovations in Peptide Based Targeted Drug Delivery to Cancer Cells"],"prefix":"10.3390","volume":"4","author":[{"given":"Yosi","family":"Gilad","sequence":"first","affiliation":[{"name":"Department of Chemical Sciences, Ariel University, Ariel 40700, Israel"},{"name":"Department of Chemical Engineering and Biotechnology, Ariel University, Ariel 40700, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Firer","sequence":"additional","affiliation":[{"name":"Department of Chemical Engineering and Biotechnology, Ariel University, Ariel 40700, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Gellerman","sequence":"additional","affiliation":[{"name":"Department of Chemical Sciences, Ariel University, Ariel 40700, Israel"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2016,5,26]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.2147\/OTT.S40947","article-title":"Targeted drug delivery via folate receptors in recurrent ovarian cancer: A review","volume":"7","author":"Marchetti","year":"2014","journal-title":"OncoTargets Ther."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.tem.2004.07.002","article-title":"Chemotherapy targeted to cancers through tumoral hormone receptors","volume":"15","author":"Schally","year":"2004","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/1756-8722-5-70","article-title":"Targeted drug delivery for cancer therapy: The other side of antibodies","volume":"5","author":"Firer","year":"2012","journal-title":"J. Hematol. Oncol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1126\/science.4001944","article-title":"Filamentous fusion phage: Novel expression vectors that display cloned antigens on the virion surface","volume":"228","author":"Smith","year":"1985","journal-title":"Science"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"4056","DOI":"10.1021\/cr000261r","article-title":"Filamentous phage display in the new millennium","volume":"105","author":"Kehoe","year":"2005","journal-title":"Chem. Rev."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.biotechadv.2010.07.004","article-title":"Phage display: Concept, innovations, applications and future","volume":"28","author":"Pande","year":"2010","journal-title":"Biotechnol. Adv."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.biotechadv.2013.04.004","article-title":"In vivo phage display\u2014A discovery tool in molecular biomedicine","volume":"31","author":"Babickova","year":"2013","journal-title":"Biotechnol. Adv."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.2174\/138161210790963788","article-title":"Peptidic tumor targeting agents: The road from phage display peptide selections to clinical applications","volume":"16","author":"Kathlynn","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"857","DOI":"10.3390\/molecules16010857","article-title":"Peptide phage display as a tool for drug discovery: Targeting membrane receptors","volume":"16","author":"Molek","year":"2011","journal-title":"Molecules"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ymeth.2012.07.006","article-title":"Deep sequencing analysis of phage libraries using illumina platform","volume":"58","author":"Matochko","year":"2012","journal-title":"Methods"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"3998","DOI":"10.1073\/pnas.81.13.3998","article-title":"Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid","volume":"81","author":"Geysen","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1002\/anie.199203673","article-title":"Multiple peptide synthesis methods and their applications. New synthetic methods (87)","volume":"31","author":"Jung","year":"1992","journal-title":"Angew. Chem. Int. Ed. Engl."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0022-1759(90)90108-8","article-title":"Multi-pin peptide synthesis strategy for T cell determinant analysis","volume":"134","author":"Maeji","year":"1990","journal-title":"J. Immunol. Methods"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0022-1759(02)00137-0","article-title":"The spot-synthesis technique: Synthetic peptide arrays on membrane supports\u2014Principles and applications","volume":"267","author":"Frank","year":"2002","journal-title":"J. Immunol. Methods"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1021\/cr9600114","article-title":"The \u201cone-bead-one-compound\u201d combinatorial library method","volume":"97","author":"Lam","year":"1997","journal-title":"Chem. Rev."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S0022-1759(02)00138-2","article-title":"Multipin peptide libraries for antibody and receptor epitope screening and characterization","volume":"267","author":"Tribbick","year":"2002","journal-title":"J. Immunol. Methods"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1021\/jm501628s","article-title":"Combinatorial libraries as a tool for the discovery of novel, broad-spectrum antibacterial agents targeting the eskape pathogens","volume":"58","author":"Fleeman","year":"2015","journal-title":"J. Med. Chem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1039\/C4CS00493K","article-title":"Dynamic combinatorial chemistry: A tool to facilitate the identification of inhibitors for protein targets","volume":"44","author":"Mondal","year":"2015","journal-title":"Chem. Soc. Rev."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.2174\/0929867013372139","article-title":"Combinatorial approaches in anticancer drug discovery: Recent advances in design and synthesis","volume":"8","author":"Bhattacharyya","year":"2001","journal-title":"Curr. Med. Chem."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.2174\/1386207053258497","article-title":"Synthetic peptide arrays and peptide combinatorial libraries for the exploration of protein-ligand interactions and the design of protein inhibitors","volume":"8","author":"Eichler","year":"2005","journal-title":"Comb. Chem. High Throughput Screen."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/S0301-472X(02)01008-1","article-title":"Combinatorial peptide library methods for immunobiology research","volume":"31","author":"Liu","year":"2003","journal-title":"Exp. Hematol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1021\/cr400166n","article-title":"Combinatorial peptide libraries: Mining for cell-binding peptides","volume":"114","author":"Gray","year":"2014","journal-title":"Chem. Rev."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1021\/mp700073y","article-title":"From combinatorial chemistry to cancer-targeting peptides","volume":"4","author":"Aina","year":"2007","journal-title":"Mol. Pharm."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1021\/cc800145c","article-title":"Screening of one-bead-one-peptide combinatorial library using red fluorescent dyes. Presence of positive and false positive beads","volume":"11","author":"Marani","year":"2009","journal-title":"J. Comb. Chem."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"6133","DOI":"10.1002\/anie.201101804","article-title":"Screening of a combinatorial homing peptide library for selective cellular delivery","volume":"50","author":"Svensen","year":"2011","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1126\/science.1962210","article-title":"Sequence-selective recognition of DNA by strand displacement with a thymine-substituted polyamide","volume":"254","author":"Nielsen","year":"1991","journal-title":"Science"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1021\/ja00031a062","article-title":"Peptide nucleic acids (PNA). Oligonucleotide analogs with an achiral peptide backbone","volume":"114","author":"Egholm","year":"1992","journal-title":"J. Am. Chem. Soc."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/0006-2952(94)90171-6","article-title":"Stability of peptide nucleic acids in human serum and cellular extracts","volume":"48","author":"Demidov","year":"1994","journal-title":"Biochem. Pharmacol."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Egholm, M., Behrens, C., Christensen, L., Berg, R.H., Nielsen, P.E., and Buchardt, O. (1993). Peptide nucleic acids containing adenine or guanine recognize thymine and cytosine in complementary DNA sequences. J. Chem. Soc. Chem. Commun., 800\u2013801.","DOI":"10.1039\/c39930000800"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"9677","DOI":"10.1021\/ja00050a068","article-title":"Recognition of guanine and adenine in DNA by cytosine and thymine containing peptide nucleic acids (PNA)","volume":"114","author":"Egholm","year":"1992","journal-title":"J. Am. Chem. Soc."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"9217","DOI":"10.1016\/S0040-4020(01)85612-X","article-title":"Spot-synthesis: An easy technique for the positionally addressable, parallel chemical synthesis on a membrane support","volume":"48","author":"Frank","year":"1992","journal-title":"Tetrahedron"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1038\/nprot.2007.160","article-title":"Peptide arrays on cellulose support: Spot synthesis, a time and cost efficient method for synthesis of large numbers of peptides in a parallel and addressable fashion","volume":"2","author":"Hilpert","year":"2007","journal-title":"Nat. Protoc."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0958-1669(00)00178-6","article-title":"Applications of peptide arrays prepared by the spot-technology","volume":"12","author":"Reineke","year":"2001","journal-title":"Curr. Opin. Biotechnol."},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Morris, G.E. (1996). Epitope Mapping Protocols, Humana Press.","DOI":"10.1385\/0896033759"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1016\/S0040-4039(99)00775-3","article-title":"Efficient assembly of peptomers on continuous surfaces","volume":"40","author":"Ast","year":"1999","journal-title":"Tetrahedron Lett."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1093\/nar\/25.14.2792","article-title":"Hybridisation based DNA screening on peptide nucleic acid (PNA) oligomer arrays","volume":"25","author":"Weiler","year":"1997","journal-title":"Nucleic Acids Res."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1021\/cc000012g","article-title":"Spatially addressed synthesis of amino- and amino-oxy-substituted 1,3,5-triazine arrays on polymeric membranes","volume":"2","author":"Scharn","year":"2000","journal-title":"J. Comb. Chem."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1023\/B:MODI.0000036253.04738.ac","article-title":"New planar substrates for the in situ synthesis of peptide arrays","volume":"8","author":"Zander","year":"2004","journal-title":"Mol. Divers."},{"key":"ref_39","first-page":"296","article-title":"Evaluation of cotton as a carrier for solid-phase peptide synthesis","volume":"4","author":"Eichler","year":"1991","journal-title":"Pept. Res."},{"key":"ref_40","first-page":"275","article-title":"Multiple peptide synthesis on polypropylene membranes for rapid screening of bioactive peptides","volume":"5","author":"Wang","year":"1992","journal-title":"Pept. Res."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/S0040-4039(96)02508-7","article-title":"Stable attachment of the hmb-linker to continuous cellulose membranes for parallel solid phase spot synthesis","volume":"38","author":"Hoffmann","year":"1997","journal-title":"Tetrahedron Lett."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1016\/S0040-4039(00)00019-8","article-title":"Highly parallel nano-synthesis of cleavable peptide-dye conjugates on cellulose membranes","volume":"41","author":"Licha","year":"2000","journal-title":"Tetrahedron Lett."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0168-1656(95)00062-U","article-title":"Simultaneous and combinatorial chemical synthesis techniques for the generation and screening of molecular diversity","volume":"41","author":"Frank","year":"1995","journal-title":"J. Biotechnol."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00726-005-0289-3","article-title":"Strategies to improve plasma half life time of peptide and protein drugs","volume":"30","author":"Werle","year":"2006","journal-title":"Amino Acids"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1023\/A:1018953309913","article-title":"Peptide stability in drug development. II. Effect of single amino acid substitution and glycosylation on peptide reactivity in human serum","volume":"10","author":"Powell","year":"1993","journal-title":"Pharm. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1136\/gut.35.3_Suppl.S1","article-title":"Somatostatin and somatostatin analogs: Pharmacokinetics and pharmacodynamic effects","volume":"35","author":"Harris","year":"1994","journal-title":"Gut"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.tibtech.2011.01.004","article-title":"Computational design of peptide ligands","volume":"29","author":"Vanhee","year":"2011","journal-title":"Trends Biotechnol."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1016\/j.jmb.2009.03.038","article-title":"Structure-based prediction of the saccharomyces cerevisiae SH3\u2013ligand interactions","volume":"388","author":"Beltrao","year":"2009","journal-title":"J. Mol. Biol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jmb.2005.02.046","article-title":"Recognizing and defining true ras binding domains II: In silico prediction based on homology modelling and energy calculations","volume":"348","author":"Kiel","year":"2005","journal-title":"J. Mol. Biol."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1021\/jm00148a029","article-title":"Conformationally restricted C-terminal peptides of substance P. Synthesis, mass spectral analysis and pharmacological properties","volume":"28","author":"Theodoropoulos","year":"1985","journal-title":"J. Med. Chem."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/S0006-291X(85)80211-4","article-title":"Conformationally restricted cyclic analogues of substance P: Insight into the receptor binding process","volume":"127","author":"Darman","year":"1985","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1665","DOI":"10.1021\/jm0100281","article-title":"Human somatostatin receptor specificity of backbone-cyclic analogues containing novel sulfur building units","volume":"45","author":"Gazal","year":"2002","journal-title":"J. Med. Chem."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1034\/j.1399-3011.2001.00936.x","article-title":"Synthesis of novel protected N\u03b1(\u03c9-thioalkyl) amino acid building units and their incorporation in backbone cyclic disulfide and thioetheric bridged peptides","volume":"58","author":"Gazal","year":"2001","journal-title":"J. Pept. Res. Off. J. Am. Pept. Soc."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1002\/psc.348","article-title":"A bioactive somatostatin analog without a type ii' beta-turn: Synthesis and conformational analysis in solution","volume":"7","author":"Jiang","year":"2001","journal-title":"J. Pept. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1016\/j.peptides.2003.09.020","article-title":"Novel gly building units for backbone cyclization: Synthesis and incorporation into model peptides","volume":"24","author":"Gazal","year":"2003","journal-title":"Peptides"},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1046\/j.1397-002x.2000.0780.x","article-title":"Facile synthesis of orthogonally protected amino acid building blocks for combinatorial n-backbone cyclic peptide chemistry","volume":"57","author":"Gellerman","year":"2001","journal-title":"J. Pept. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/0024-3205(93)90113-H","article-title":"The use of positional scanning synthetic peptide combinatorial libraries for the rapid determination of opioid receptor ligands","volume":"52","author":"Dooley","year":"1993","journal-title":"Life Sci."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1016\/j.ejmech.2015.11.032","article-title":"Identification of novel cyclic lipopeptides from a positional scanning combinatorial library with enhanced antibacterial and antibiofilm activities","volume":"108","author":"Bionda","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/309030a0","article-title":"Cell attachment activity of fibronectin can be duplicated by small synthetic fragments of the molecule","volume":"309","author":"Pierschbacher","year":"1984","journal-title":"Nature"},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"5985","DOI":"10.1073\/pnas.81.19.5985","article-title":"Variants of the cell recognition site of fibronectin that retain attachment-promoting activity","volume":"81","author":"Pierschbacher","year":"1984","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1083\/jcb.99.1.29","article-title":"Dualistic nature of adhesive protein function: Fibronectin and its biologically active peptide fragments can autoinhibit fibronectin function","volume":"99","author":"Yamada","year":"1984","journal-title":"J. Cell Biol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"11891","DOI":"10.1016\/S0021-9258(17)38962-7","article-title":"The tetrapeptide analogue of the cell attachment site of fibronectin inhibits platelet aggregation and fibrinogen binding to activated platelets","volume":"260","author":"Gartner","year":"1985","journal-title":"J. Biol. Chem."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"8057","DOI":"10.1073\/pnas.82.23.8057","article-title":"The effect of arg-gly-asp-containing peptides on fibrinogen and von willebrand factor binding to platelets","volume":"82","author":"Plow","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.1002\/j.1460-2075.1985.tb03965.x","article-title":"Complete amino acid sequence of human vitronectin deduced from cdna. Similarity of cell attachment sites in vitronectin and fibronectin","volume":"4","author":"Suzuki","year":"1985","journal-title":"EMBO J."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/0092-8674(85)90101-1","article-title":"Interaction of fibronectin with its receptor on platelets","volume":"42","author":"Gardner","year":"1985","journal-title":"Cell"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1083\/jcb.80.2.403","article-title":"Studies on the function of cell surface glycoproteins. II. Possible role of surface glycoproteins in the control of cytoskeletal organization and surface morphology","volume":"80","author":"Damsky","year":"1979","journal-title":"J. Cell Biol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/0014-4827(85)90164-8","article-title":"A monoclonal antibody identifies a glycoprotein complex involved in cell-substratum adhesion","volume":"157","author":"Knudsen","year":"1985","journal-title":"Exp. Cell Res."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1083\/jcb.95.2.654","article-title":"A monoclonal antibody detaches embryonic skeletal muscle from extracellular matrices","volume":"95","author":"Neff","year":"1982","journal-title":"J. Cell Biol."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/jcb.1982.240180209","article-title":"Monoclonal antibodies which alter the morphology of cultured chick myogenic cells","volume":"18","author":"Greve","year":"1982","journal-title":"J. Cell. Biochem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1083\/jcb.94.1.179","article-title":"Cell surface molecules and fibronectin-mediated cell adhesion: Effect of proteolytic digestion of membrane proteins","volume":"94","author":"Tarone","year":"1982","journal-title":"J. Cell Biol."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1126\/science.4012302","article-title":"Selective inhibition of fibronectin-mediated cell adhesion by monoclonal antibodies to a cell-surface glycoprotein","volume":"228","author":"Brown","year":"1985","journal-title":"Science"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/jcb.240250206","article-title":"Characterization of a 140Kd cell surface glycoprotein involved in myoblast adhesion","volume":"25","author":"Chapman","year":"1984","journal-title":"J. Cell. Biochem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1083\/jcb.103.2.429","article-title":"Fibronectin-plasma membrane interaction in the adhesion of hemopoietic cells","volume":"103","author":"Giancotti","year":"1986","journal-title":"J. Cell Biol."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0092-8674(85)90322-8","article-title":"Identification and isolation of a 140 kd cell surface glycoprotein with properties expected of a fibronectin receptor","volume":"40","author":"Pytela","year":"1985","journal-title":"Cell"},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0092-8674(86)90744-0","article-title":"Structure of integrin, a glycoprotein involved in the transmembrane linkage between fibronectin and actin","volume":"46","author":"Tamkun","year":"1986","journal-title":"Cell"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0092-8674(02)00971-6","article-title":"Integrins: Bidirectional, allosteric signaling machines","volume":"110","author":"Hynes","year":"2002","journal-title":"Cell"},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1146\/annurev.cb.11.110195.003001","article-title":"Integrins: Emerging paradigms of signal transduction","volume":"11","author":"Schwartz","year":"1995","journal-title":"Annu. Rev. Cell Dev. Biol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"10324","DOI":"10.1158\/0008-5472.CAN-04-4098","article-title":"A direct test of potential roles for \u03b23 and \u03b25 integrins in growth and metastasis of murine mammary carcinomas","volume":"65","author":"Taverna","year":"2005","journal-title":"Cancer Res."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1006\/bbrc.1996.1313","article-title":"Integrin \u03b23 cDNA transfection into a highly metastatic \u03b1v\u03b23-negative human melanoma cell line inhibits invasion and experimental metastasis","volume":"226","author":"Danen","year":"1996","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"ref_80","first-page":"79","article-title":"The relationship between bone metastasis from human breast cancer and integrin \u03b1v\u03b23 expression","volume":"25","author":"Takayama","year":"2005","journal-title":"Anticancer Res."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1038\/nrc2353","article-title":"Integrins in angiogenesis and lymphangiogenesis","volume":"8","author":"Avraamides","year":"2008","journal-title":"Nat. Rev. Cancer"},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"3759","DOI":"10.1038\/sj.onc.1208452","article-title":"\u03b1v\u03b23 integrin regulates heregulin (HRG)-induced cell proliferation and survival in breast cancer","volume":"24","author":"Vellon","year":"2005","journal-title":"Oncogene"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"3752","DOI":"10.1158\/0008-5472.CAN-06-3851","article-title":"Src Phosphorylates Tyr284 in TGF-\u03b2 Type II Receptor and Regulates TGF-\u03b2 Stimulation of p38 MAPK during Breast Cancer Cell Proliferation and Invasion","volume":"67","author":"Galliher","year":"2007","journal-title":"Canser Res."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s10585-007-9132-4","article-title":"Cnto 95, a fully human anti \u03b1v integrin antibody, inhibits cell signaling, migration, invasion, and spontaneous metastasis of human breast cancer cells","volume":"25","author":"Chen","year":"2008","journal-title":"Clin. Exp. Metastasis"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"5892","DOI":"10.1074\/jbc.271.10.5892","article-title":"Role of 3 integrins in melanoma cell adhesion to activated platelets under flow","volume":"271","author":"Habermann","year":"1996","journal-title":"J. Biol. Chem."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1083\/jcb.200609004","article-title":"Av\u03b23 and \u03b15\u03b21 integrin recycling pathways dictate downstream rho kinase signaling to regulate persistent cell migration","volume":"177","author":"White","year":"2007","journal-title":"J. Cell Biol."},{"key":"ref_87","first-page":"6757","article-title":"Integrin distribution in malignant melanoma: Association of the \u03b23 subunit with tumor progression","volume":"50","author":"Albelda","year":"1990","journal-title":"Cancer Res."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1073\/pnas.89.5.1557","article-title":"Role of the alpha v beta 3 integrin in human melanoma cell invasion","volume":"89","author":"Seftor","year":"1992","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1038\/nrm1490","article-title":"Integrin signalling during tumour progression","volume":"5","author":"Guo","year":"2004","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/nrc2748","article-title":"Integrins in cancer: Biological implications and therapeutic opportunities","volume":"10","author":"Desgrosellier","year":"2010","journal-title":"Nat. Rev. Cancer"},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nrd3266","article-title":"Integrins as therapeutic targets: Lessons and opportunities","volume":"9","author":"Cox","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2174\/187152010794728639","article-title":"Cilengitide: The first anti-angiogenic small molecule drug candidate. Design, synthesis and clinical evaluation","volume":"10","author":"Rechenmacher","year":"2010","journal-title":"Anticancer Agents Med. Chem."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"189","DOI":"10.7150\/thno\/v01p0189","article-title":"Integrin targeted delivery of chemotherapeutics","volume":"1","author":"Chen","year":"2011","journal-title":"Theranostics"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1126\/science.279.5349.377","article-title":"Cancer treatment by targeted drug delivery to tumor vasculature in a mouse model","volume":"279","author":"Arap","year":"1998","journal-title":"Science"},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.1158\/1535-7163.1593.3.12","article-title":"Doxorubicin-formaldehyde conjugates targeting \u03b1v\u03b23 integrin","volume":"3","author":"Burkhart","year":"2004","journal-title":"Mol. Cancer Ther."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1021\/jm049165z","article-title":"Synthesis and biological evaluation of dimeric RGD peptide\u2013paclitaxel conjugate as a model for integrin-targeted drug delivery","volume":"48","author":"Chen","year":"2005","journal-title":"J. Med. Chem."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.jconrel.2009.08.011","article-title":"Targeting of tumor endothelium by RGD-grafted PLGA-nanoparticles loaded with paclitaxel","volume":"140","author":"Danhier","year":"2009","journal-title":"J. Control. Release"},{"key":"ref_98","first-page":"1776","article-title":"Pegylated Arg-Gly-Asp peptide: 64Cu labeling and pet imaging of brain tumor \u03b1v\u03b23-integrin expression","volume":"45","author":"Chen","year":"2004","journal-title":"J. Nucl. Med."},{"key":"ref_99","first-page":"1707","article-title":"Micropet imaging of glioma integrin \u03b1v\u03b23 expression using 64cu-labeled tetrameric rgd peptide","volume":"46","author":"Wu","year":"2005","journal-title":"J. Nucl. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1021\/jm020577m","article-title":"Docking studies on \u03b1v\u03b23 integrin ligands:\u2009 Pharmacophore refinement and implications for drug design","volume":"46","author":"Marinelli","year":"2003","journal-title":"J. Med. Chem."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1126\/science.1069040","article-title":"Crystal structure of the extracellular segment of integrin \u03b1v\u03b23 in complex with an Arg-Gly-Asp ligand","volume":"296","author":"Xiong","year":"2002","journal-title":"Science"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1186\/bcr2579","article-title":"Novel design principles enable specific targeting of imaging and therapeutic agents to necrotic domains in breast tumors","volume":"12","author":"Goldshaid","year":"2010","journal-title":"Breast Cancer Res."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/protein\/gzh055","article-title":"Novel RGD lipopeptides for the targeting of liposomes to integrin-expressing endothelial and melanoma cells","volume":"17","author":"Bach","year":"2004","journal-title":"Protein Eng. Des. Sel."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1126\/science.1183057","article-title":"Coadministration of a tumor-penetrating peptide enhances the efficacy of cancer drugs","volume":"328","author":"Sugahara","year":"2010","journal-title":"Science"},{"key":"ref_105","unstructured":"Jonczyk, A., Goodman, S., Diefenbach, B., Sutter, A., Holzemann, G., Kessler, H., and Dechantsreiter, M. (1999). Cyclic Adhesion Inhibitors. (US5866540 A), U.S. Patent."},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1021\/jm970832g","article-title":"n-methylated cyclic RGD peptides as highly active and selective \u03b1v\u03b23 integrin antagonists","volume":"42","author":"Dechantsreiter","year":"1999","journal-title":"J. Med. Chem."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s11523-010-0156-3","article-title":"Targeting integrins in malignant glioma","volume":"5","author":"Tabatabai","year":"2010","journal-title":"Target. Oncol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"7461","DOI":"10.1021\/ja9603721","article-title":"Structural and functional aspects of RGD-containing cyclic pentapeptides as highly potent and selective integrin \u03b1v\u03b23 antagonists","volume":"118","author":"Haubner","year":"1996","journal-title":"J. Am. Chem. Soc."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.bmc.2015.12.020","article-title":"Synthesis, biological studies and molecular dynamics of new anticancer rgd-based peptide conjugates for targeted drug delivery","volume":"24","author":"Gilad","year":"2016","journal-title":"Bioorg. Med. Chem."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"5255","DOI":"10.1073\/pnas.82.16.5255","article-title":"Identical short peptide sequences in unrelated proteins can have different conformations: A testing ground for theories of immune recognition","volume":"82","author":"Wilson","year":"1985","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1002\/anie.198205121","article-title":"Conformation and biological activity of cyclic peptides","volume":"21","author":"Kessler","year":"1982","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_112","doi-asserted-by":"crossref","unstructured":"Gilad, Y., Noy, E., Senderowitz, H., Albeck, A., Firer, M.A., and Gellerman, G. (2015). Dual-drug rgd conjugates provide enhanced cytotoxicity to melanoma and non-small lung cancer cells. Biopolymers.","DOI":"10.1002\/bip.22800"},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1097\/CAD.0b013e32835bb17a","article-title":"Drug resistance to chlorambucil in murine B-cell leukemic cells is overcome by its conjugation to a targeting peptide","volume":"24","author":"Gellerman","year":"2013","journal-title":"Anti-Cancer Drugs"},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1002\/1097-0045(20001001)45:2<158::AID-PROS10>3.0.CO;2-K","article-title":"Peptide analogs in the therapy of prostate cancer","volume":"45","author":"Schally","year":"2000","journal-title":"Prostate"},{"key":"ref_115","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/313231a0","article-title":"Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist","volume":"313","author":"Miller","year":"1985","journal-title":"Nature"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1023\/A:1006267327007","article-title":"Effective treatment of advanced estrogen-independent MXT mouse mammary cancers with targeted cytotoxic LH-RH analogs","volume":"56","author":"Szepeshazi","year":"1999","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_117","first-page":"3742","article-title":"Targeted doxorubicin-containing luteinizing hormone-releasing hormone analogue AN-152 inhibits the growth of doxorubicin-resistant MX-1 human breast cancers","volume":"9","author":"Bajo","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.1002\/(SICI)1097-0142(19990615)85:12<2608::AID-CNCR17>3.0.CO;2-H","article-title":"Complete regression of MX-1 human breast carcinoma xenografts after targeted chemotherapy with a cytotoxic analog of luteinizing hormone-releasing hormone, AN-207","volume":"85","author":"Kahan","year":"1999","journal-title":"Cancer"},{"key":"ref_119","first-page":"4505","article-title":"Preclinical evaluation of targeted cytotoxic luteinizing hormone-releasing hormone analogue AN-152 in androgen-sensitive and insensitive prostate cancers","volume":"9","author":"Letsch","year":"2003","journal-title":"Clin. Cancer Res."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0304-3835(01)00734-0","article-title":"Inhibition of in vivo proliferation of MDA-PCa-2b human prostate cancer by a targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207","volume":"176","author":"Plonowski","year":"2002","journal-title":"Cancer Lett."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1067\/mob.2002.124278","article-title":"Antitumor effects of the cytotoxic luteinizing hormone-releasing hormone analog AN-152 on human endometrial and ovarian cancers xenografted into nude mice","volume":"187","author":"Grundker","year":"2002","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1093\/jnci\/89.23.1803","article-title":"Growth inhibition of human ovarian cancers by cytotoxic analogues of luteinizing hormone-releasing hormone","volume":"89","author":"Miyazaki","year":"1997","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/S0002-9378(99)70600-9","article-title":"Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits growth of OV-1063 human epithelial ovarian cancers in nude mice","volume":"180","author":"Miyazaki","year":"1999","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1097\/00001813-200210000-00007","article-title":"Effective treatment of experimental ES-2 human ovarian cancers with a cytotoxic analog of luteinizing hormone-releasing hormone AN-207","volume":"13","author":"Arencibia","year":"2002","journal-title":"Anticancer Drugs"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/(SICI)1097-0045(19990201)38:2<151::AID-PROS9>3.0.CO;2-#","article-title":"Targeted cytotoxic analog of luteinizing hormone-releasing hormone AN-207 inhibits the growth of PC-82 human prostate cancer in nude mice","volume":"38","author":"Koppan","year":"1999","journal-title":"Prostate"},{"key":"ref_126","doi-asserted-by":"crossref","first-page":"7269","DOI":"10.1073\/pnas.93.14.7269","article-title":"Cytotoxic analogs of luteinizing hormone-releasing hormone containing doxorubicin or 2-pyrrolinodoxorubicin, a derivative 500\u20131000 times more potent","volume":"93","author":"Nagy","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_127","first-page":"4158","article-title":"Effective treatment of metastatic MDA-MB-435 human estrogen-independent breast carcinomas with a targeted cytotoxic analogue of luteinizing hormone-releasing hormone AN-207","volume":"6","author":"Chatzistamou","year":"2000","journal-title":"Clin. Cancer Res."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1023\/A:1006352401912","article-title":"Administration of a targeted cytotoxic analog of luteinizing hormone-releasing hormone inhibits growth of estrogen-independent MDA-MB-231 human breast cancers in nude mice","volume":"59","author":"Kahan","year":"2000","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_129","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1517\/13543784.2012.685128","article-title":"AEZS-108: A targeted cytotoxic analog of LHRH for the treatment of cancers positive for LHRH receptors","volume":"21","author":"Engel","year":"2012","journal-title":"Expert Opin. Investig. Drugs"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"6102","DOI":"10.3748\/wjg.v20.i20.6102","article-title":"Targeted therapy in advanced metastatic colorectal cancer: Current concepts and perspectives","volume":"20","author":"Hohla","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"6277","DOI":"10.1158\/1078-0432.CCR-14-0489","article-title":"Phase I, dose-escalation study of the targeted cytotoxic LHRH analog AEZS-108 in patients with castration- and taxane-resistant prostate cancer","volume":"20","author":"Liu","year":"2014","journal-title":"Clin. Cancer Res."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/pros.10259","article-title":"Human prostate cancer cells and xenografts are targeted and destroyed through luteinizing hormone releasing hormone receptors","volume":"56","author":"Leuschner","year":"2003","journal-title":"Prostate"},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S0014-5793(00)01469-1","article-title":"Cytotoxic activity of a recombinant GnRH-PAP fusion toxin on human tumor cell lines","volume":"472","author":"Schlick","year":"2000","journal-title":"FEBS Lett."},{"key":"ref_134","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0168-3659(03)00209-8","article-title":"Molecular targeting of drug delivery systems to ovarian cancer by BH3 and LHRH peptides","volume":"91","author":"Dharap","year":"2003","journal-title":"J. Control. Release"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"12962","DOI":"10.1073\/pnas.0504274102","article-title":"Tumor-specific targeting of an anticancer drug delivery system by LHRH peptide","volume":"102","author":"Dharap","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"ref_136","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/frne.1999.0183","article-title":"Somatostatin and its receptor family","volume":"20","author":"Patel","year":"1999","journal-title":"Front. Neuroendocrinol."},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1038\/aps.2009.59","article-title":"The antiproliferative effects of somatostatin receptor subtype 2 in breast cancer cells","volume":"30","author":"He","year":"2009","journal-title":"Acta Pharmacol. Sin."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1080\/02841850903127477","article-title":"Quantitative assessment of 99mTc-depreotide uptake in patients with non-small-cell lung cancer: Immunohistochemical correlations","volume":"50","author":"Herlin","year":"2009","journal-title":"Acta Radiol."},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"726","DOI":"10.4161\/cbt.3.8.962","article-title":"The effect of somatostatin and sstr3 on proliferation and apoptosis of gastric cancer cells","volume":"3","author":"Hu","year":"2004","journal-title":"Cancer Biol. Ther."},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1155\/2010\/532094","article-title":"Immunohistochemical expression and localization of somatostatin receptor subtypes in androgen ablated prostate cancer","volume":"33","author":"Mazzucchelli","year":"2010","journal-title":"Anal. Cell. Pathol."},{"key":"ref_141","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1177\/030089161109700514","article-title":"Detection of somatostatin receptor subtypes 2 and 5 by somatostatin receptor scintigraphy and immunohistochemistry: Clinical implications in the diagnostic and therapeutic management of gastroenteropancreatic neuroendocrine tumors","volume":"97","author":"Sclafani","year":"2011","journal-title":"Tumori"},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"RA169","DOI":"10.12659\/MSM.881892","article-title":"Somatostatin analogues in advanced hepatocellular carcinoma: An updated systematic review and meta-analysis of randomized controlled trials","volume":"17","author":"Ji","year":"2011","journal-title":"Med. Sci. Monit."},{"key":"ref_143","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1007\/BF00181765","article-title":"Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: The rotterdam experience with more than 1000 patients","volume":"20","author":"Krenning","year":"1993","journal-title":"Eur. J. Nuclear Med."},{"key":"ref_144","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0026-0495(92)90038-C","article-title":"111In-octreotide scintigraphy in oncology","volume":"41","author":"Krenning","year":"1992","journal-title":"Metab. Clin. Exp."},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1021\/ar800188e","article-title":"Tumor imaging and therapy using radiolabeled somatostatin analogues","volume":"42","author":"Breeman","year":"2009","journal-title":"Acc. Chem. Res."},{"key":"ref_146","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1053\/snuc.2002.31564","article-title":"Somatostatin receptor imaging of non-small cell lung cancer with 99mTc depreotide","volume":"32","author":"Menda","year":"2002","journal-title":"Semin. Nucl. Med."},{"key":"ref_147","first-page":"708","article-title":"An intrapatient comparison of 99mTc-EDDA\/HYNIC-TOC with 111In-DTPA-octreotide for diagnosis of somatostatin receptor-expressing tumors","volume":"44","author":"Gabriel","year":"2003","journal-title":"J. Nucl. Med."},{"key":"ref_148","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/156720111793663633","article-title":"Somatostatin receptor-targeted anti-cancer therapy","volume":"8","author":"Sun","year":"2011","journal-title":"Curr. Drug Deliv."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1080\/10717540490446125","article-title":"Effects of camptothecin conjugated to a somatostatin analog vector on growth of tumor cell lines in culture and related tumors in rodents","volume":"11","author":"Sun","year":"2004","journal-title":"Drug Deliv."},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.canlet.2006.02.016","article-title":"A conjugate of camptothecin and a somatostatin analog against prostate cancer cell invasion via a possible signaling pathway involving PI3K\/AKT, \u03b1v\u03b23\/\u03b1v\u03b25 and MMP-2\/-9","volume":"246","author":"Sun","year":"2007","journal-title":"Cancer Lett."},{"key":"ref_151","first-page":"491","article-title":"Targeted chemotherapy using a cytotoxic somatostatin conjugate to inhibit tumor growth and metastasis in nude mice","volume":"2","author":"Sun","year":"2008","journal-title":"Clin. Med. Oncol."},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S1074-5521(00)00131-9","article-title":"Targeting delivery of paclitaxel into tumor cells via somatostatin receptor endocytosis","volume":"7","author":"Huang","year":"2000","journal-title":"Chem. Biol."},{"key":"ref_153","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1021\/mp0700514","article-title":"Targeted therapy of breast and gynecological cancers with cytotoxic analogues of peptide hormones","volume":"4","author":"Engel","year":"2007","journal-title":"Mol. Pharm."},{"key":"ref_154","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/eje.0.1410001","article-title":"Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors","volume":"141","author":"Schally","year":"1999","journal-title":"Eur. J. Endocrinol."},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1677\/erc.1.01022","article-title":"Targeted cytotoxic bombesin analog AN-215 effectively inhibits experimental human breast cancers with a low induction of multi-drug resistance proteins","volume":"12","author":"Engel","year":"2005","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_156","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.coph.2005.04.017","article-title":"Drug-conjugated monoclonal antibodies for the treatment of cancer","volume":"5","author":"Lambert","year":"2005","journal-title":"Curr. Opin. Pharmacol."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.cbpa.2010.06.170","article-title":"Antibody-drug conjugates: Targeted drug delivery for cancer","volume":"14","author":"Alley","year":"2010","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1517\/14712598.2012.685153","article-title":"Designing immunoconjugates for cancer therapy","volume":"12","author":"Govindan","year":"2012","journal-title":"Expert Opin. Biol. Ther."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.jconrel.2012.01.026","article-title":"Antibody\u2013drug conjugates: Basic concepts, examples and future perspectives","volume":"161","author":"Casi","year":"2012","journal-title":"J. Control. Release"},{"key":"ref_160","doi-asserted-by":"crossref","first-page":"982","DOI":"10.2174\/156800909790192365","article-title":"Antibody-drug conjugate targets","volume":"9","author":"Teicher","year":"2009","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/bip.22694","article-title":"Synthesis, drug release, and biological evaluation of new anticancer drug\u2013bioconjugates containing somatostatin backbone cyclic analog as a targeting moiety","volume":"104","author":"Redko","year":"2015","journal-title":"Pept. Sci."},{"key":"ref_162","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.lungcan.2005.07.009","article-title":"Targeting small-cell lung cancer with novel fluorescent analogs of somatostatin","volume":"50","author":"Kostenich","year":"2005","journal-title":"Lung Cancer"},{"key":"ref_163","first-page":"1139","article-title":"Bombesin receptor subtypes in human cancers: Detection with the universal radioligand 125I-[d-Tyr6, \u03b2-Ala11, Phe13, Nle14] bombesin(6\u201314)","volume":"8","author":"Reubi","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"ref_164","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.107.07108","article-title":"International union of pharmacology. LXVIII. Mammalian bombesin receptors: Nomenclature, distribution, pharmacology, signaling, and functions in normal and disease states","volume":"60","author":"Jensen","year":"2008","journal-title":"Pharmacol. Rev."},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/316823a0","article-title":"Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer","volume":"316","author":"Cuttitta","year":"1985","journal-title":"Nature"},{"key":"ref_166","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1126\/science.6272398","article-title":"High levels of intracellular bombesin characterize human small-cell lung carcinoma","volume":"214","author":"Moody","year":"1981","journal-title":"Science"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/0024-3205(85)90413-8","article-title":"High affinity receptors for bombesin\/GRP-like peptides on human small cell lung cancer","volume":"37","author":"Moody","year":"1985","journal-title":"Life Sci."},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1124\/jpet.106.104141","article-title":"In vitro and in vivo antitumor effects of cytotoxic camptothecin-bombesin conjugates are mediated by specific interaction with cellular bombesin receptors","volume":"318","author":"Moody","year":"2006","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_169","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1021\/bc050224c","article-title":"Single-drug multiligand conjugates:\u2009 Synthesis and preliminary cytotoxicity evaluation of a paclitaxel\u2212dipeptide \u201cscorpion\u201d molecule","volume":"17","author":"Safavy","year":"2006","journal-title":"Bioconj. Chem."},{"key":"ref_170","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1073\/pnas.94.2.652","article-title":"Design, synthesis, and in vitro evaluation of cytotoxic analogs of bombesin-like peptides containing doxorubicin or its intensely potent derivative,\u20092-pyrrolinodoxorubicin","volume":"94","author":"Nagy","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_171","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.lfs.2008.01.019","article-title":"Bombesin marine toxin conjugates inhibit the growth of lung cancer cells","volume":"82","author":"Moody","year":"2008","journal-title":"Life Sci."},{"key":"ref_172","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1021\/mp900280s","article-title":"Selective apoptotic killing of solid and hematologic tumor cells by bombesin-targeted delivery of mitochondria-disrupting peptides","volume":"7","author":"Cai","year":"2010","journal-title":"Mol. Pharm."},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2967\/jnumed.107.045054","article-title":"Bombesin receptor antagonists may be preferable to agonists for tumor targeting","volume":"49","author":"Cescato","year":"2008","journal-title":"J. Nucl. Med."},{"key":"ref_174","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/nrurol.2013.42","article-title":"Targeting grpr in urological cancers\u2014from basic research to clinical application","volume":"10","author":"Mansi","year":"2013","journal-title":"Nat. Rev. Urol."},{"key":"ref_175","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.peptides.2015.04.026","article-title":"Insights into bombesin receptors and ligands: Highlighting recent advances","volume":"72","author":"Moreno","year":"2015","journal-title":"Peptides"},{"key":"ref_176","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1002\/anie.201508445","article-title":"Miniap-4: A venom-inspired peptidomimetic for brain delivery","volume":"55","author":"Ciudad","year":"2016","journal-title":"Angew. Chem. Int. Ed."},{"key":"ref_177","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1158\/1535-7163.MCT-11-0566","article-title":"Safety, pharmacokinetics, and activity of GRN1005, a novel conjugate of angiopep-2, a peptide facilitating brain penetration, and paclitaxel, in patients with advanced solid tumors","volume":"11","author":"Kurzrock","year":"2012","journal-title":"Mol. Cancer Ther."},{"key":"ref_178","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1158\/1078-0432.CCR-12-2481","article-title":"Phase I study of GRN1005 in recurrent malignant glioma","volume":"19","author":"Drappatz","year":"2013","journal-title":"Clin. Cancer Res."},{"key":"ref_179","doi-asserted-by":"crossref","first-page":"112","DOI":"10.20517\/2394-4722.2015.78","article-title":"Tailored nanocarriers and bioconjugates for combating glioblastoma and other brain tumors","volume":"2","author":"Elamrawy","year":"2016","journal-title":"J. Cancer Metastasis Treat."},{"key":"ref_180","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1021\/jm9016637","article-title":"New angiopep-modified doxorubicin (ANG1007) and etoposide (ANG1009) chemotherapeutics with increased brain penetration","volume":"53","author":"Che","year":"2010","journal-title":"J. Med. Chem."},{"key":"ref_181","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1158\/1535-7163.MCT-14-0399","article-title":"ANG4043, a novel brain-penetrant peptide\u2013mAb conjugate, is efficacious against HER2-positive intracranial tumors in mice","volume":"14","author":"Regina","year":"2015","journal-title":"Mol. Cancer Ther."},{"key":"ref_182","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1007\/s11095-009-9964-5","article-title":"Uptake of ANG1005, a novel paclitaxel derivative, through the blood-brain barrier into brain and experimental brain metastases of breast cancer","volume":"26","author":"Thomas","year":"2009","journal-title":"Pharm. Res."},{"key":"ref_183","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1016\/j.biomaterials.2011.02.044","article-title":"Angiopep-conjugated poly(ethylene glycol)-co-poly(epsilon-caprolactone) nanoparticles as dual-targeting drug delivery system for brain glioma","volume":"32","author":"Xin","year":"2011","journal-title":"Biomaterials"},{"key":"ref_184","doi-asserted-by":"crossref","first-page":"197","DOI":"10.3109\/1061186X.2010.483517","article-title":"Poly(ethylene glycol)-block-poly(d,l-lactide acid) micelles anchored with angiopep-2 for brain-targeting delivery","volume":"19","author":"Shen","year":"2011","journal-title":"J. Drug Target."},{"key":"ref_185","first-page":"916","article-title":"Co-delivery of pEGFP-hTRAIL and paclitaxel to brain glioma mediated by an angiopep-conjugated liposome","volume":"33","author":"Sun","year":"2012","journal-title":"Biomaterials"},{"key":"ref_186","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.2174\/1381612053507594","article-title":"Targeting cytotoxic conjugates of somatostatin, luteinizing hormone-releasing hormone and bombesin to cancers expressing their receptors: A \"smarter\" chemotherapy","volume":"11","author":"Nagy","year":"2005","journal-title":"Curr. Pharm. Des."},{"key":"ref_187","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1002\/ijc.26132","article-title":"[DLys6]-luteinizing hormone releasing hormone-curcumin conjugate inhibits pancreatic cancer cell growth in vitro and in vivo","volume":"129","author":"Aggarwal","year":"2011","journal-title":"Int. J. Cancer"},{"key":"ref_188","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.drup.2005.10.002","article-title":"RGD-based strategies for selective delivery of therapeutics and imaging agents to the tumour vasculature","volume":"8","author":"Temming","year":"2005","journal-title":"Drug Res. Updates"},{"key":"ref_189","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1021\/mp3002733","article-title":"RGD-based strategies to target alpha(v) beta(3) integrin in cancer therapy and diagnosis","volume":"9","author":"Danhier","year":"2012","journal-title":"Mol. Pharm."},{"key":"ref_190","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1158\/1535-7163.MCT-07-2084","article-title":"Integrin-targeted imaging and therapy with RGD4C-TNF fusion protein","volume":"7","author":"Wang","year":"2008","journal-title":"Mol. Cancer Ther."},{"key":"ref_191","first-page":"901","article-title":"Design, synthesis, and biological evaluation of a dual tumor-specific motive containing integrin-targeted plasmin-cleavable doxorubicin prodrug","volume":"1","author":"Broxterman","year":"2002","journal-title":"Mol. Cancer Ther."},{"key":"ref_192","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.colsurfb.2014.11.004","article-title":"RGD peptide-modified multifunctional dendrimer platform for drug encapsulation and targeted inhibition of cancer cells","volume":"125","author":"He","year":"2015","journal-title":"Colloids Surf. B Biointerfaces"},{"key":"ref_193","doi-asserted-by":"crossref","first-page":"8583","DOI":"10.1021\/nn402662d","article-title":"Cyclic RGD-linked polymeric micelles for targeted delivery of platinum anticancer drugs to glioblastoma through the blood\u2013brain tumor barrier","volume":"7","author":"Miura","year":"2013","journal-title":"ACS Nano"},{"key":"ref_194","doi-asserted-by":"crossref","first-page":"9343","DOI":"10.1073\/pnas.0803728105","article-title":"Nanoparticle-mediated drug delivery to tumor vasculature suppresses metastasis","volume":"105","author":"Murphy","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_195","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.bmc.2009.11.019","article-title":"Novel tumor-targeted rgd peptide\u2013camptothecin conjugates: Synthesis and biological evaluation","volume":"18","author":"Ni","year":"2010","journal-title":"Bioorg. Med. Chem."},{"key":"ref_196","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.jconrel.2009.12.020","article-title":"Cyclic rgd conjugated poly(ethylene glycol)-co-poly(lactic acid) micelle enhances paclitaxel anti-glioblastoma effect","volume":"143","author":"Zhan","year":"2010","journal-title":"J. Control. Release"},{"key":"ref_197","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1016\/j.biomaterials.2011.01.073","article-title":"Integrin-assisted drug delivery of nano-scaled polymer therapeutics bearing paclitaxel","volume":"32","author":"Miller","year":"2011","journal-title":"Biomaterials"},{"key":"ref_198","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1021\/bc800117r","article-title":"In vitro and in vivo evaluation of doxorubicin conjugates with the divalent peptide E-[c(RGDfK)2] that targets integrin \u03b1v\u03b23","volume":"19","author":"Ryppa","year":"2008","journal-title":"Bioconj. Chem."},{"key":"ref_199","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ijpharm.2008.09.055","article-title":"In vitro and in vivo evaluation of a paclitaxel conjugate with the divalent peptide E-[c(RGDfK)2] that targets integrin \u03b1v\u03b23","volume":"368","author":"Ryppa","year":"2009","journal-title":"Int. J. Pharm."},{"key":"ref_200","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1210\/er.2002-0007","article-title":"Peptide receptors as molecular targets for cancer diagnosis and therapy","volume":"24","author":"Reubi","year":"2003","journal-title":"Endocr. Rev."},{"key":"ref_201","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1073\/pnas.95.4.1794","article-title":"Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative,\u20092-pyrrolinodoxorubicin","volume":"95","author":"Nagy","year":"1998","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_202","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/0304-3835(92)90105-5","article-title":"Cytotoxic analog of somatostatin containing methotrexate inhibits growth of mia paca-2 human pancreatic cancer xenografts in nude mice","volume":"62","author":"Radulovic","year":"1992","journal-title":"Cancer Lett."},{"key":"ref_203","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1038\/sj.bjc.6690794","article-title":"Targeted cytotoxic analogue of bombesin\/gastrin-releasing peptide inhibits the growth of H-69 human small-cell lung carcinoma in nude mice","volume":"81","author":"Kiaris","year":"1999","journal-title":"Br. J. Cancer"},{"key":"ref_204","doi-asserted-by":"crossref","first-page":"4919","DOI":"10.1021\/jm990355x","article-title":"Paclitaxel derivatives for targeted therapy of cancer:\u2009 Toward the development of smart taxanes","volume":"42","author":"Safavy","year":"1999","journal-title":"J. Med. Chem."},{"key":"ref_205","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.biologicals.2015.05.006","article-title":"Antibody-drug conjugates for cancer therapy: The technological and regulatory challenges of developing drug-biologic hybrids","volume":"43","author":"Hamilton","year":"2015","journal-title":"Biologicals"},{"key":"ref_206","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.nano.2014.11.006","article-title":"Recent advances in targeted nanoparticles drug delivery to melanoma","volume":"11","author":"Li","year":"2015","journal-title":"Nanomed. Nanotechnol. Biol. Med."},{"key":"ref_207","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.molmed.2015.06.005","article-title":"Cell-penetrating peptides: Strategies for anticancer treatment","volume":"21","author":"Raucher","year":"2015","journal-title":"Trends Mol. Med."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/4\/2\/11\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T19:24:32Z","timestamp":1760210672000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/4\/2\/11"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5,26]]},"references-count":207,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2016,6]]}},"alternative-id":["biomedicines4020011"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines4020011","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,5,26]]}}}